Is Universal Next-Generation Sequencing Testing of Patients With Advanced Cancer Ready for Prime Time?-Reply
JAMA Oncol
.
2021 Jun 17.
doi: 10.1001/jamaoncol.2021.1907.
Online ahead of print.
Authors
Erin F Cobain
1
,
Arul M Chinnaiyan
2
3
4
5
6
Affiliations
1
Department of Internal Medicine, University of Michigan, Ann Arbor.
2
Michigan Center for Translational Pathology, University of Michigan, Ann Arbor.
3
Department of Pathology, University of Michigan, Ann Arbor.
4
Rogel Cancer Center, University of Michigan, Ann Arbor.
5
Department of Urology, University of Michigan, Ann Arbor.
6
Howard Hughes Medical Institute, University of Michigan, Ann Arbor.
PMID:
34137801
DOI:
10.1001/jamaoncol.2021.1907
No abstract available